This paper is in the following e-collection/theme issue:

Web-based and Mobile Health Interventions (3114) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1309) Apps, Mobile, Wearables for Diabetes (288) Diabetes Self-Management (463) Hypertension Prevention and Treatment (207)

Published on in Vol 21, No 4 (2019): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/12541, first published .
Addressing Diabetes and Poorly Controlled Hypertension: Pragmatic mHealth Self-Management Intervention

Addressing Diabetes and Poorly Controlled Hypertension: Pragmatic mHealth Self-Management Intervention

Addressing Diabetes and Poorly Controlled Hypertension: Pragmatic mHealth Self-Management Intervention

Authors of this article:

Allison A. Lewinski1 Author Orcid Image ;   Uptal D. Patel2, 3, 4 Author Orcid Image ;   Clarissa J. Diamantidis2, 5, 6 Author Orcid Image ;   Megan Oakes6 Author Orcid Image ;   Khaula Baloch7 Author Orcid Image ;   Matthew J. Crowley1, 8 Author Orcid Image ;   Jonathan Wilson9 Author Orcid Image ;   Jane Pendergast9 Author Orcid Image ;   Holly Biola10 Author Orcid Image ;   L. Ebony Boulware5 Author Orcid Image ;   Hayden B. Bosworth1, 5, 6, 11, 12 Author Orcid Image
Article Authors Cited by (22) Tweetations (29) Metrics

    Original Paper

    1Durham Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, Durham, NC, United States

    2Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, NC, United States

    3Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States

    4Gilead Sciences, Inc, Foster City, CA, United States

    5Division of General Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, NC, United States

    6Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, United States

    7Outcomes Research Group, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States

    8Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Duke University School of Medicine, Durham, NC, United States

    9Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, United States

    10Department of Family Medicine, Lincoln Community Health Center, Durham, NC, United States

    11Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, United States

    12School of Nursing, Duke University, Durham, NC, United States

    *all authors contributed equally

    Corresponding Author:

    Hayden B Bosworth, PhD

    Durham Center of Innovation to Accelerate Discovery and Practice Transformation

    Durham Veterans Affairs Health Care System

    Attn: HSR&D COIN (558/152)

    508 Fulton St

    Durham, NC,

    United States

    Phone: 1 919 286 0411 ext 7101

    Email: hayden.bosworth@duke.edu


    Background: Patients with diabetes and poorly controlled hypertension are at increased risk for adverse renal and cardiovascular outcomes. Identifying these patients early and addressing modifiable risk factors is central to delaying renal complications such as diabetic kidney disease. Mobile health (mHealth), a relatively inexpensive and easily scalable technology, can facilitate patient-centered care and promote engagement in self-management, particularly for patients of lower socioeconomic status. Thus, mHealth may be a cost-effective way to deliver self-management education and support.

    Objective: This feasibility study aimed to build a population management program by identifying patients with diabetes and poorly controlled hypertension who were at risk for adverse renal outcomes and evaluate a multifactorial intervention to address medication self-management. We recruited patients from a federally qualified health center (FQHC) in an underserved, diverse county in the southeastern United States.

    Methods: Patients were identified via electronic health record. Inclusion criteria were age between 18 and 75 years, diagnosis of type 2 diabetes, poorly controlled hypertension over the last 12 months (mean clinic systolic blood pressure [SBP] ≥140 mm Hg and/or diastolic blood pressure [DBP] ≥90 mm Hg), access to a mobile phone, and ability to receive text messages and emails. The intervention consisted of monthly telephone calls for 6 months by a case manager and weekly, one-way informational text messages. Engagement was defined as the number of phone calls completed during the intervention; individuals who completed 4 or more calls were considered engaged. The primary outcome was change in SBP at the conclusion of the intervention.

    Results: Of the 141 patients enrolled, 84.0% (118/141) of patients completed 1 or more phone calls and had follow-up SBP measurements for analysis. These patients were on average 56.9 years of age, predominately female (73/118, 61.9%), and nonwhite by self-report (103/118, 87.3%). The proportion of participants with poor baseline SBP control (50/118, 42.4%) did not change significantly at study completion (53/118, 44.9%) (P=.64). Participants who completed 4 or more phone calls (98/118, 83.1%) did not experience a statistically significant decrease in SBP when compared to those who completed fewer calls.

    Conclusion: We did not reduce uncontrolled hypertension even among the more highly engaged. However, 83% of a predominately minority and low-income population completed at least 67% of the multimodal mHealth intervention. Findings suggest that combining an automated electronic health record system to identify at-risk patients with a tailored mHealth protocol can provide education to this population. While this intervention was insufficient to effect behavioral change resulting in better hypertension control, it does suggest that this FQHC population will engage in low-cost population health applications with a potentially promising impact.

    Trial Registration: ClinicalTrials.gov NCT02418091; https://clinicaltrials.gov/ct2/show/NCT02418091 (Archived by WebCite at http://www.webcitation.org/76RBvacVU)

    J Med Internet Res 2019;21(4):e12541

    doi:10.2196/12541

    Keywords

    telemedicine; cardiovascular diseases; diabetes mellitus type 2; vulnerable populations; renal insufficiency; professional-patient relations; hypertension 


    Diabetes and hypertension are two of the most prevalent chronic illnesses worldwide. Patients with comorbid diabetes and hypertension are at greater risk for progressive renal and cardiovascular complications, including diabetic kidney disease (DKD) [1-6]. Improving long-term outcomes in this high-risk group depends on identifying patients with diabetes and poorly controlled hypertension, addressing modifiable risk factors, and ensuring access to optimal treatment and education early in the patient’s disease trajectory [4,7].

    The incidence and prevalence of diabetes and hypertension continue to disproportionately impact individuals who are minorities and/or of lower socioeconomic status populations [7-9]. Reasons for higher rates of diabetes and hypertension in these populations can include limited access to quality medical care, low health literacy, and lack of insurance [7,10,11]. These challenges and barriers to engaging in self-management place patients of lower socioeconomic status populations at risk for poorer health and adverse renal and cardiovascular outcomes [12]. Identifying methods to deliver personalized, disease-specific support may help decrease the potential impact of diabetes and poorly controlled hypertension.

    Patients with diabetes and poorly controlled hypertension benefit from aggressive treatment that improves control of modifiable risk factors such as management of blood glucose, blood pressure, diet, exercise, and weight and smoking cessation [13-15]. Simultaneously addressing these factors may preserve renal function and delay a decline in renal function and death [7-9]. Patient-centered interventions that address multiple factors and facilitate personalized problem solving may be more effective than interventions with a generalized approach [3].

    Mobile health (mHealth) is one way to provide patient-centered information and promote engagement in self-management for patients who are at high risk for DKD. Mobile health interventions are effective ways to change behaviors in individuals with chronic illnesses such as diabetes and hypertension [16-18]. Interventions via mHealth have high potential reach, as a large percentage of US adults have a mobile phone [19], including individuals with low socioeconomic status [20-22]. Additionally, mHealth technologies are inexpensive and can be easily scaled, thus increasing the potential for behavioral intervention dissemination. However, there has been a lack of studies using mHealth to reduce risk factors among ethnic and racial minorities and low-income individuals who are at particularly high risk for poor renal and cardiovascular outcomes [23,24].

    The purpose of this feasibility study was to pilot test an mHealth intervention among individuals with diabetes and poorly controlled hypertension. The intervention included tailored behavioral-educational components with a focus on disease self-management.


    Study Design

    This was a single-arm, pragmatic study designed to implement a 6-month intervention. This multifactorial intervention simultaneously addressed multiple risk factors for adverse renal outcomes through a combination of patient self-monitoring, behavioral therapies, and education that optimized adherence and improvements in health behavior self-efficacy. As a proxy for improvements in these process measures, we examined whether the intervention was associated with a positive impact on systolic blood pressure. Duke University’s institutional review board approved this study (Pro00052081), and this study was registered with ClinicalTrials.gov (NCT02418091).

    Setting

    We recruited patients from a federally qualified health center (FQHC) in a midsize city in the southeastern United States. We chose this FQHC due to the high incidence of poorly controlled diabetes and hypertension in this underserved population. In 2017, this FQHC provided comprehensive primary and preventive care to over 33,500 unique individuals. This FQHC serves a population that is predominantly Latinx (47%) or black (39%), and many patients in this clinic system (50% of adults and 24% of children) are uninsured. Overall, patients seeking care in this clinic are lower income: 38% of patient households make less than 100% of the federal poverty level and only 19% make above 100% of the federal poverty level (43% did not provided income documentation).

    Recruitment and Enrollment

    We identified eligible patients using the FQHC’s electronic health record (EHR). Inclusion criteria for this study included age between 18 and 75 years, diagnosis of type 2 diabetes (International Classification of Disease [ICD]-9 codes 250.x0, 250.x2; ICD-10 codes E11.0-E11.9), poorly controlled hypertension (1-year mean clinic systolic blood pressure [SBP] ≥140 mm Hg and/or diastolic blood pressure [DBP] ≥90 mm Hg), and access to a mobile phone and ability to receive text messages and emails. Exclusion criteria included inability to speak English, residence in a nursing home or long-term care facility or receipt of home health care, or a current diagnosis of pancreatic insufficiency or diabetes secondary to pancreatitis. We excluded patients who self-reported alcohol use of more than 14 alcoholic beverages per week because this study was not designed to address substance abuse behaviors.

    We identified patients using the FQHC’s EHR and then screened and identified eligible patients. Eligible patients received a letter from their primary care provider requesting study participation. After a 10-day period in which potential patients could opt out of the study, patients were contacted by the call center affiliated with the local academic clinical research organization. Patients were informed and consented over the phone using an institutional review board–approved script. All patients who verbally consented to the study were enrolled.

    Simultaneous Risk Factor Control Using Telehealth to Slow Progression of Diabetic Kidney Disease Automated Population Program

    The Simultaneous Risk Factor Control Using Telehealth to Slow Progression of Diabetic Kidney Disease Automated Population Program (STOP-DKD APP) consisted of two novel platforms. The first platform was an electronic registry that used the clinic’s EHR to identify the target population (eg, patients with diabetes and poorly controlled hypertension). This was combined with a second electronic platform that delivered an evidence-based behavioral intervention to improve self-management comprising educational content on diabetes and hypertension [25]. The goal of the intervention was not to replace clinic-based management but to supplement it in order to more efficiently intensify therapy that may otherwise be left until future appointments. Information for all eligible patients was entered into the STOP-DKD APP platform. The STOP-DKD APP intervention was guided by three behavioral science models: chronic care model [26,27], health decision model [28], and the transtheoretical model [29]. These complementary models informed the design of the intervention to slow DKD progression in the population.

    The chronic care model describes factors that can improve functional and clinical outcomes, particularly in chronic conditions [26,27]. Patients with DKD and uncontrolled hypertension often receive suboptimal care due to fragmented and poorly designed health systems. Thus, the model acknowledges that a substantial portion of chronic care takes place outside of formal health care settings and highlights six core elements for the provision of optimal care of patients with chronic disease. The STOP-DKD APP intervention addressed the core elements described in the chronic care model [26,27] in order to create a more proactive provider team and more engaged patient by (1) engaging health systems interested in improvement strategies, (2) leveraging an innovative clinical information system to identify study patients and community resources to tailor information and feedback, (3) using decision support informed by health behavior models to optimize patient self-management, and (4) redesigning the delivery system by using case managers to facilitate management of complex medication regimens in close communication with participant primary care providers [30-32]. These intervention strategies created a more proactive provider team and more active patient.

    We used the health decision model to guide the selection of behaviors related to treatment adherence, diabetes, and poorly controlled hypertension [28]. For patients with DKD and poorly controlled hypertension, the complexity of care requires that appropriate behavior change theories be applied toward understanding behaviors related to treatment adherence. To focus on health decisions, the health decision model draws upon other behavioral models to combine the influences of health beliefs and modifying factors with contributions from the patient preference literature, including important factors such as memory and the experience of side effects associated with medications [28,29,33,34]. The health decision model also identifies potential behavioral factors that may explain poor disease control related to treatment adherence by examining factors that hinder or promote health behaviors.

    Behavior change theories are also used for understanding behaviors related to treatment adherence. Understanding the factors that hinder or promote health behaviors is central to the transtheoretical model [29], which we used to guide the incorporation of patient-centered, tailored information and feedback as the intervention focused heavily on the initiation and maintenance phases of behavior change [29]. While a generic health care–administered intervention may improve treatment adherence through reminders, a tailored intervention can address issues that are specifically relevant to each patient.

    Thus, drawing on the stages of change [29] and the revised health decision model [28,29], the STOP DKD APP intervention helped patients to (1) set healthy goals and gain self-efficacy, (2) implement healthy behaviors and monitor performance, and (3) maintain the behaviors and associated risk factor control over time [35,36]. Together, these models directed the structure, content, and format of the intervention in order to optimize medical management of this population while encouraging patient engagement in and adherence to their self-management behaviors.

    The telephone-based intervention was administered by a call center using nonclinician case managers. The intervention consisted of (1) monthly telephone calls for 6 months, (2) monthly emails that summarized the content covered with the case manager during the monthly phone call, and (3) weekly text messages. Table 1 provides examples of the content in the text messages and monthly calls. Patients received medication adherence information and e-reminders to take DKD-related medications and self-monitor their health status (eg, SBP, weight). This study did not include medical management for hypertension. All intervention components were designed to be culturally sensitive, and content addressed self-management facilitators and barriers common in this population. Additionally, all content provided was tailored to patient responses about self-management behaviors, medication adherence, smoking status, and prescribed medications. Patient responses were obtained during interactions with the case manager or the interactive text messages received during the intervention. All content was presented at a literacy level below a 6th grade reading level.

    The monthly call was a review of education and self-management topics related to diabetes, hypertension, and hyperlipidemia. During these calls, the case manager reviewed the patient’s current medications, changes in medication status, or side effects the patient was experiencing and then provided self-management content based on the patient’s self-reported health status. Phone calls provided patients the opportunity to obtain personalized, disease-specific information and feedback. If a patient could not be reached on schedule, the case manager attempted to complete the phone call at the next scheduled call time. Once a call was completed, the call schedule was adjusted accordingly. Following the completion of each monthly phone call, patients were sent an email that summarized the content discussed in the phone call.

    Patients received text messages containing information related to self-management and medication adherence on diabetes and hypertension, including messages on side effects, risks and benefits of medication treatment, and barriers to medication adherence. These text messages prompted patients to engage in self-management behaviors (“Remember to carry a snack or a source of sugar with you in case your blood sugar gets low”), provided education (“Exercise lowers your risk for heart disease and stroke, relieves stress, and strengthens your heart, muscles, and bones”), and offered suggestions (“You can decrease your salt intake by cutting back on fast foods and processed foods such as canned soups and vegetables and frozen dinners” and “To help prevent low blood sugar, eat your meals and snacks at the same time each day. Do not skip meals”). Text messages were sent 3 times each week around 6 pm for 6 months.

    Measures

    The focus of the intervention was to optimize medication management related to treatment for diabetes and hypertension. The primary study outcome was change in SBP, operationalized as controlled (SBP <140 mm Hg) or poorly controlled (SBP ≥140 mm Hg) from baseline to 90 days after the last completed phone call. Baseline SBP was defined as the SBP closest to study enrollment within a window from 1 year prior to 14 days into the study period. Completion SBP was defined as the closest SBP measurement to 90 days after the last completed phone call from a window spanning last call day to 180 days later. Our selection of these intervals represents our pragmatic approach to address potential sparsity of data for some individuals. Engagement was recorded as the number of completed monthly calls at the time of each SBP measurement. Individuals who completed 4 or more calls were considered engaged during the study period for pre-post comparisons, while those completing fewer were considered nonengaged.

    Analyses

    We examined engagement in the intervention to determine feasibility of providing an mHealth intervention to patients from an FQHC. We defined level of engagement as the number of completed phone calls during the intervention.

    We used two statistical methods to evaluate the effectiveness of the STOP-DKD APP intervention. First, we used the McNemar test [37,38] to compare the proportion of patients who went from having a controlled blood pressure (SBP <140 mm Hg) or poorly controlled pressure (SBP ≥140 mm Hg) at baseline to the opposite category at the end of the study period. Second, using linear regression, we compared change in SBP over the time-in-study of those patients who had a controlled SBP at baseline to those patients who had a high SBP at baseline, adjusting for the level of study engagement and its interaction with baseline SBP. This approach allowed testing for a change over time, whether greater participation in the intervention was associated with a greater impact on SBP, and if that impact was different for those with high versus controlled SBP at baseline.

    Table 1. Description of case manager call and text message topics.
    MonthPhone callsText messages
    1Review of medications and side effectsWeekly medication reminders and study introduction

    		Hypertension and cardiovascular disease knowledgeStress and increased blood pressure
    2Review of medications and side effectsWeekly medication reminders

    		Hypoglycemia and foot careHyperglycemia recognition

    		Diabetes medications and side effectsTobacco use
    3Review of medications and side effectsWeekly medication reminders

    		Hyperlipidemia medications and side effectsAlcohol

    		Diet and weightSleep health

    		Hyperlipidemia knowledgeCholesterol and blood pressure knowledge
    4Review of medications and side effectsWeekly medication reminders

    		Hypertension medicationsPatient and provider or clinic communication

    		ExerciseBlood pressure and diabetes knowledge

    		SleepDiet (lowering carbohydrates)
    5Review of medications and side effectsWeekly medication reminders

    		DepressionDiet (carbohydrates and fiber)

    		Tobacco useCholesterol knowledge
    6Review of medications, side effects, and aspirin useWeekly medication reminders

    		Alcohol knowledgeBlood pressure and blood sugar goals

    		Patient-provider interactionPatient and provider or clinic communication

    Sample Characteristics

    We contacted 379 patients about the STOP DKD APP study; of those patients, we excluded 238. We enrolled 141 patients from May 2015 through January 2016 (see Figure 1 for the Consolidated Standards of Reporting Trials diagram). In total, 127 patients completed at least one phone call. Of those 127 patients, 125 had a baseline SBP and 118 had both a baseline and follow-up SBP. Therefore, the following analyses focused on the 118 patients (118/141, 83.7%) who completed 1 or more phone call and had both a baseline and follow-up SBP. These analyses do not include patients who withdrew from the study (6/141, 4.3%), were lost to follow-up (4/141, 2.8%), did not complete any phone calls (4/141, 2.8%), or did not have an eligible baseline or follow-up SBP (9/141, 6.4%).

    Among the 118 individuals, the mean age was 56.9 years. Patients were primarily female (73/118, 61.9%), self-identified as nonwhite or black (103/118, 87.3%), and had a high school education or more (91/118, 77.1%). Most had no insurance (35/118, 29.7%) or government-funded support or special programs (53/118, 44.9%), while 25.4% (30/118) had private/commercial insurance. In regard to baseline clinical characteristics, the mean 12-month prior SBP of the sample was 139.5 (SD 19.8) mm Hg and mean DBP was 82.5 (SD 11.2) mm Hg and most had an estimated glomerular filtration rate (eGFR) >60 (74/118, 62.7%). The sample is fully described in Table 2.

    ‎
    Figure 1. Consolidated Standards of Reporting Trials diagram.
    View this figure
    Table 2. Baseline demographic and clinical characteristics (n=118).
    CharacteristicValue
    Age in years, mean (SD)56.9 (7.6)
    Gender, female, n (%)73 (61.9)
    Race, n (%) 

         		White15 (12.7)

         		Black99 (83.9)

         		Other4 (3.4)
    Ethnicity (Hispanic) , n (%) 

         		Yes2 (1.7)

         		No114 (96.6)

         		Refused2 (1.7)

         		Marital status, married, n (%)25 (21.2)

         		Missed medication, yes, n (%)57 (48.3)
    Insurance status, n (%) 

         		Self-pay35 (29.7)

         		Commercial30 (25.4)

         		Government or special program53 (44.9)
    Access to computer, n (%) 

         		Yes54 (45.8)

         		No63 (53.4)

         		Missing1 (0.8)

         		Education, high school graduate or greater, n (%)91 (77.1)

         		Ability to do usual activities, no problems reported, n (%)65 (55.1)

         		Ability to take care of self, no problems washing or dressing, n (%)101 (85.6)

         		Self-rated health at baseline (0 to 100), mean (SD)65.6 (23.6)

         		Systolic blood pressure (mm Hg), mean (SD)139.5 (19.8)

         		Diastolic blood pressure (mm Hg), mean (SD)82.5 (11.2)
    Estimated glomerular filtration rate, n (%) 

         		<6024 (20.3)

         		>6074 (62.7)
     Missing20 (16.9)
    Table 3. Baseline demographic and clinical characteristics by engagement.
    CharacteristicNonengaged (n=20)Engaged (n=98)
    Age in years, mean (SD)50.3 (8.8)58.2 (6.6)
    Gender, female, n (%)16 (80)57 (58)
    Race, n (%)  

         		White3 (15)12 (12)

         		Black17 (85)82 (84)

         		Other0 (0)4 (4)
    Ethnicity (Hispanic), n (%)  

         		Yes0 (0)2 (2)

         		No20 (100)94 (96)

         		Refused0 (0)2 (2)

         		Marital status, married, n (%)5 (25)20 (20)

         		Missed medication, yes, n (%)10 (50)47 (48)
    Insurance status, n (%)  

         		Self-pay5 (25)30 (31)

         		Commercial4 (20)26 (27)

         		Government or special program11 (55)42 (43)
    Access to computer, n (%)  

         		Yes9 (45)45 (46)

         		No11 (55)52 (53)

         		Missing0 (0)1 (1)

         		Education, high school graduate or greater, n (%)17 (85)74 (76)

         		Ability to do usual activities, no problems reported, n (%)8 (40)57 (58)

         		Ability to take care of self, no problems washing or dressing, n (%)18 (90)83 (85)

         		Self-rated health at baseline (0-100), mean (SD)70.1 (23.7)64.6 (23.5)

         		Systolic blood pressure (mm Hg), mean (SD)138.2 (21.9)139.8 (19.5)

         		Diastolic blood pressure (mm Hg), mean (SD)85.1 (7.6)82.0 (11.8)
    Estimated glomerular filtration rate, n (%)  

         		<603 (15)21 (21)

         		>6013 (65)61 (62)

         		Missing4 (20)16 (16)

    Engagement

    We noted a few differences between engaged and nonengaged patients. Engaged patients (completed 4 or more phone calls) had a significantly higher mean age (P=.001, Wilcoxon rank-sum test) and were marginally more likely to be male (P=.08, Fisher exact test) and have a diagnosis of hypertension than nonengaged patients (P=.09, Fisher exact test). The baseline demographic and clinical characteristics by study engagement over the course of the intervention are presented in Table 3, and other than those reported above, no other differences were seen between engaged and nonengaged participants.

    Table 4. Pre-post change in systolic blood pressure control status.
    Baseline SBPPostintervention SBPa

    		ControlPoor controlTotal
    Control46 (39.0)22 (18.6)68
    Poor control19 (16.1)31 (26.3)50
    Total6553118

    aSBP: systolic blood pressure.

    Clinical Outcomes

    The proportion of patients with poorly controlled SBP at the start of the study (50/118, 42.4%) did not change significantly at study completion (53/118, 44.9%) (P=.64). The proportions who switched from in control (defined as SBP <140 mm Hg) to poor control (defined as SBP ≥140 mm Hg) (22/118, 18.6%) and poor control to in control (19/118, 16.1%) were comparable (P=.64, McNemar test) (Table 4).

    The McNemar test does not consider the magnitude of changes over time, and slight changes could reclassify a patient into the other group. Thus, we compared the rates of change in SBP while accounting for baseline SBP and engagement with the study. Participants who completed 4 or more phone calls (98/118, 83.1%) did not experience a statistically significant decrease in SBP when compared to those who completed fewer calls.


    Principal Findings

    This study is among the first to examine the use of mHealth supported with phone calls from nonclinician case managers in a predominately minority and low-income sample. We successfully recruited and engaged a sample of patients with diabetes and poorly controlled hypertension from an FQHC for a multifactorial behavioral-educational population intervention primarily using the EHR. Individuals who completed 4 or more phone calls (out of 6) did not experience a statistical decrease in SBP relative to those patients who were not as engaged. Overall, the findings provide insight into designing population health management programs that aim to address modifiable risk factors for patients with both diabetes and poorly controlled hypertension.

    The identification of patients using a system linked to an EHR can quickly detect patients at high risk for poor diabetes outcomes. EHRs can facilitate population health management because they facilitate the collection of patient data on a large scale and enable a more rapid and efficient analysis of these patient data [39]. The early identification of patients at risk for poor health outcomes, such as those with diabetes and poorly controlled hypertension, can decrease the progression of renal and cardiovascular complications and potentially decrease disparities in treatment and care [40]. The STOP-DKD APP study successfully facilitated the identification of patients at risk for DKD via a community clinic’s EHR and provided education tailored to each patient.

    Our study successfully recruited a black sample with limited financial resources from an FQHC for an mHealth intervention. The sample was highly engaged, with the majority completing 4 or more case manager–administered, telephone-delivered self-management education calls. One potential reason for high engagement could be the bidirectional monthly interaction with a case manager. These frequent encounters with the case manager may have addressed the patient’s current questions about self-management and medication adherence in a more timely fashion than an episodic appointment with a medical provider [41,42]. This study’s pragmatic design was an additional strength as there was no in-person contact, the intervention was administered by telephone, and blood pressure was assessed via each patient’s EHR. Taken together, these strengths indicate that mHealth interventions in which routine encounters are delivered by nonclinicians can be used with high-risk, low-income populations without placing undue burden on clinicians at community health clinics.

    There are several potential explanations for why this multifactorial intervention was not as impactful as hypothesized. First, our sample’s blood pressure was relatively well controlled at baseline, which may have limited our ability to detect the clinical impact of improved SBP. Second, the intervention’s dose of self-management education and/or the length of the intervention may not have been sufficient to affect cardiovascular disease risk factor control in this low-income population. Additionally, clinic staff may have given more attention to patients at baseline who had poorly controlled hypertension and may have focused less on those patients who had controlled blood pressure at baseline. Collectively, our findings reflect the literature that further research is needed on pragmatic, multifactorial interventions that address chronic illness self-management [43]. A greater understanding of this population of low-income individuals with chronic illness will help identify the optimal intervention dose and length, intervention strategies, and message content to impact metabolic outcomes.

    Another reason for the limited impact on blood pressure may have been due to the use of routine clinic measurements for outcome ascertainment. The variance in frequency of blood pressure values for each patient may have impacted our results due to the imprecise nature of voluntary patient visits to the FQHC. For example, to obtain the SBP and DBP from the FQHC’s EHR, we aimed to get as close as possible to a 3-month follow-up window during the 6-month study period. As a result, this limited our ability to collect data that was in sync with the completed phone calls. The SBP measurements used in this study for each individual were a result of the patients voluntarily going to the FQHC and having a blood pressure value logged into the system during the intervention time period. Additionally, the precision of the blood pressure readings may have been low, as only one blood pressure reading may have been taken during each clinic visit [44]. Variability in routine clinic blood pressure measurement has been increasingly recognized [45,46], so although university-affiliated clinics have standard procedures for BP measurement, it is possible that routine clinic practice and all available clinic data may have introduced error into our analysis. Our experience highlights the challenges of using clinical measures for outcomes and indicates the need for further research on pragmatic methods to accurately obtain clinical outcome data from patients who receive care at an FQHC.

    Limitations

    There are several limitations to this study. First, we sampled individuals who received medical care at an FQHC, which may limit generalizability of these results. Second, the patients in this study had a mean SBP of 140 mm Hg at baseline. The wide variance in the mean SBP may be because we included patients with any SBP over 140 mm Hg, which may have led to a mean SBP at baseline near the target threshold. Third, potential reasons for the minimal results seen with this study could be because of limited data in the EHR due to patients’ variable clinic visits and the lack of standardization of the blood pressure measurement. In addition, the study’s inclusion criteria may not have been stringent enough to identify patients with poorly controlled hypertension who may have benefited from inclusion in this intervention. However, despite these limitations we believe the findings from this study add to the literature on engagement in mHealth interventions among patients who receive care at an FQHC.

    Conclusions

    The findings from this study indicate that the combination of an automated system that identifies at-risk patients using an EHR in addition to tailored education via mHealth can successfully be used to provide self-management education to a high-risk, low-income population. The findings from this study indicate that population health applications can be easily applied with a potentially promising impact in an FQHC.

    Acknowledgments

    Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award numbers R34, DK102166-01, and P30DK096493. UDP was also supported by R01DK93938 and P30DK096493 prior to joining Gilead Sciences in 2016. CJD was supported by grants funded by the National Institute of Diabetes and Digestive and Kidney Diseases (K23-DK099385 and R01-DK093938). HBB was supported by a Research Career Scientist award from Veterans Affairs (VA) Health Services Research and Development (HSR&D 08-027). Support for AAL was provided by the VA Office of Academic Affiliations (TPH 21-000), and publication support was provided by Durham VA Health Services Research Center of Innovation funding (CIN 13-410). The content is solely the responsibility of the authors and does not necessarily reflect the position or policy of Duke University, the US Department of Veterans Affairs, or the US government.

    Conflicts of Interest

    HBB reports receiving research funds from Sanofi, Otsuka, Johnson and Johnson, and Improved Patient Outcomes as well as consulting funds from Sanofi. UDP is employed by Gilead Sciences, Inc.

    1. Losito A, Pittavini L, Zampi I, Zampi E. Characteristics of the relationship of kidney dysfunction with cardiovascular disease in high risk patients with diabetes. Int J Nephrol 2016;2016:7180784 [FREE Full text] [CrossRef] [Medline]
    2. Leehey DJ, Zhang JH, Emanuele NV, Whaley-Connell A, Palevsky PM, Reilly RF, VA NEPHRON-D Study Group. BP and renal outcomes in diabetic kidney disease: the Veterans Affairs Nephropathy in Diabetes Trial. Clin J Am Soc Nephrol 2015 Dec 07;10(12):2159-2169 [FREE Full text] [CrossRef] [Medline]
    3. Hill CJ, Cardwell CR, Patterson CC, Maxwell AP, Magee GM, Young RJ, et al. Chronic kidney disease and diabetes in the National Health Service: a cross-sectional survey of the U.K. national diabetes audit. Diabet Med 2014 Apr;31(4):448-454. [CrossRef] [Medline]
    4. National Diabetes Statistics Report, 2017: estimates of diabetes and its burden in the United States.: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2017.   URL: https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf [accessed 2018-01-31] [WebCite Cache]
    5. Kumar S, de Lusignan S, McGovern A, Correa A, Hriskova M, Gatenby P, et al. Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care. BMJ 2018 Dec 14;360:k342. [CrossRef] [Medline]
    6. Chang P, Chien L, Lin Y, Chiu W, Chiou H. Simultaneous control of glycemic, blood pressure, and lipid significantly reduce the risk of renal progression in diabetes patients. Eur J Intern Med 2016 Dec;36:87-92. [CrossRef] [Medline]
    7. Duru OK, Middleton T, Tewari MK, Norris K. The landscape of diabetic kidney disease in the United States. Curr Diab Rep 2018 Feb 19;18(3):14 [FREE Full text] [CrossRef] [Medline]
    8. Murphy D, McCulloch CE, Lin F, Banerjee T, Bragg-Gresham JL, Eberhardt MS, Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team. Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med 2016 Oct 04;165(7):473-481 [FREE Full text] [CrossRef] [Medline]
    9. Kidney disease statistics for the United States.: National Institute of Diabetes and Digestive and Kidney Diseases; 2016.   URL: https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease [accessed 2018-03-06] [WebCite Cache]
    10. Moreau C, Sando KR, Zambrano DH. Assessing the effect of pharmacist care on diabetes-related outcomes in a rural outpatient clinic: a retrospective case-control study. Ann Pharmacother 2017 Jun;51(6):473-478. [CrossRef] [Medline]
    11. Young BA, Katz R, Boulware LE, Kestenbaum B, de Boer IH, Wang W, et al. Risk factors for rapid kidney function decline among African Americans: the Jackson Heart Study (JHS). Am J Kidney Dis 2016 Dec;68(2):229-239 [FREE Full text] [CrossRef] [Medline]
    12. Lo C, Ilic D, Teede H, Cass A, Fulcher G, Gallagher M, et al. The perspectives of patients on health-care for co-morbid diabetes and chronic kidney disease: a qualitative study. PLoS One 2016;11(1):e0146615 [FREE Full text] [CrossRef] [Medline]
    13. Polonia J, Azevedo A, Monte M, Silva JA, Bertoquini S. Annual deterioration of renal function in hypertensive patients with and without diabetes. Vasc Health Risk Manag 2017;13:231-237 [FREE Full text] [CrossRef] [Medline]
    14. Lovre D, Shah S, Sihota A, Fonseca VA. Managing diabetes and cardiovascular risk in chronic kidney disease patients. Endocrinol Metab Clin North Am 2018 Dec;47(1):237-257. [CrossRef] [Medline]
    15. Anderson RJ, Bahn GD, Emanuele NV, Marks JB, Duckworth WC, VADT Study Group. Blood pressure and pulse pressure effects on renal outcomes in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care 2014 Oct;37(10):2782-2788 [FREE Full text] [CrossRef] [Medline]
    16. Marcolino MS, Oliveira JAQ, D'Agostino M, Ribeiro AL, Alkmim MBM, Novillo-Ortiz D. The impact of mHealth interventions: systematic review of systematic reviews. JMIR Mhealth Uhealth 2018 Jan 17;6(1):e23 [FREE Full text] [CrossRef] [Medline]
    17. Park LG, Howie-Esquivel J, Chung ML, Dracup K. A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Educ Couns 2014 Feb;94(2):261-268. [CrossRef] [Medline]
    18. Dobson R, Whittaker R, Jiang Y, Maddison R, Shepherd M, McNamara C, et al. Effectiveness of text message based, diabetes self management support programme (SMS4BG): two arm, parallel randomised controlled trial. BMJ 2018 May 17;361:k1959. [CrossRef]
    19. Mobile fact sheet. Washington: Pew Internet and American Life Project; 2018.   URL: http://www.pewinternet.org/fact-sheet/mobile/ [accessed 2018-04-10] [WebCite Cache]
    20. Graetz I, Gordon N, Fung V, Hamity C, Reed ME. The digital divide and patient portals: internet access explained differences in patient portal use for secure messaging by age, race, and income. Med Care 2016 Aug;54(8):772-779. [CrossRef] [Medline]
    21. Kruse RL, Koopman RJ, Wakefield BJ, Wakefield DS, Keplinger LE, Canfield SM, et al. Internet use by primary care patients: where is the digital divide? Fam Med 2012 May;44(5):342-347 [FREE Full text] [Medline]
    22. López L, Green AR, Tan-McGrory A, King R, Betancourt JR. Bridging the digital divide in health care: the role of health information technology in addressing racial and ethnic disparities. Jt Comm J Qual Patient Saf 2011 Oct;37(10):437-445. [Medline]
    23. Lee ES, Vedanthan R, Jeemon P, Kamano JH, Kudesia P, Rajan V, et al. Quality improvement for cardiovascular disease care in low- and middle-income countries: a systematic review. PLoS One 2016;11(6):e0157036 [FREE Full text] [CrossRef] [Medline]
    24. Hamine S, Gerth-Guyette E, Faulx D, Green BB, Ginsburg AS. Impact of mHealth chronic disease management on treatment adherence and patient outcomes: a systematic review. J Med Internet Res 2015;17(2):e52 [FREE Full text] [CrossRef] [Medline]
    25. Diamantidis CJ, Bosworth HB, Oakes MM, Davenport CA, Pendergast JF, Patel S, et al. Simultaneous Risk Factor Control Using Telehealth to Slow Progression of Diabetic Kidney Disease (STOP-DKD) study: protocol and baseline characteristics of a randomized controlled trial. Contemp Clin Trials 2018 Jun;69:28-39. [CrossRef] [Medline]
    26. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA 2002 Oct 9;288(14):1775-1779. [Medline]
    27. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA 2002 Oct 16;288(15):1909-1914. [Medline]
    28. Bosworth HB, Oddone EZ. A model of psychosocial and cultural antecedents of blood pressure control. J Natl Med Assoc 2002 Apr;94(4):236-248. [Medline]
    29. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983 Jun;51(3):390-395. [Medline]
    30. Renders CM, Valk GD, Griffin SJ, Wagner EH, Eijk VJT, Assendelft WJ. Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care 2001 Oct;24(10):1821-1833. [Medline]
    31. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2002(2):CD000011. [CrossRef] [Medline]
    32. Sarkar U, Handley MA, Gupta R, Tang A, Murphy E, Seligman HK, et al. Use of an interactive, telephone-based self-management support program to identify adverse events among ambulatory diabetes patients. J Gen Intern Med 2008 Apr;23(4):459-465 [FREE Full text] [CrossRef] [Medline]
    33. Bosworth H, Oddone E, Weinberger M. Patient Treatment Adherence: Concepts, Interventions, and Measurement. Mahwah: Lawrence Erlbaum Associates; 2006.
    34. Becker MH, Maiman LA. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care 1975 Jan;13(1):10-24. [Medline]
    35. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Advances Behav Res Ther 1978 Jan;1(4):139-161. [CrossRef]
    36. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA 2002 Nov 20;288(19):2469-2475. [Medline]
    37. Khalili M, Wong RJ. Underserved does not mean undeserved: unfurling the HCV care in the safety net. Dig Dis Sci 2018 Dec;63(12):3250-3252. [CrossRef] [Medline]
    38. Agresti A. Categorical Data Analysis. Hoboken: Wiley-Interscience; 2013.
    39. Vaghefi I, Hughes JB, Law S, Lortie M, Leaver C, Lapointe L. Understanding the impact of electronic medical record use on practice-based population health management: a mixed-method study. JMIR Med Inform 2016 Apr 04;4(2):e10 [FREE Full text] [CrossRef] [Medline]
    40. Schmittdiel JA, Gopalan A, Lin MW, Banerjee S, Chau CV, Adams AS. Population health management for diabetes: health care system-level approaches for improving quality and addressing disparities. Curr Diab Rep 2017 Dec;17(5):31 [FREE Full text] [CrossRef] [Medline]
    41. Ishani A, Greer N, Taylor BC, Kubes L, Cole P, Atwood M, et al. Effect of nurse case management compared with usual care on controlling cardiovascular risk factors in patients with diabetes: a randomized controlled trial. Diabetes Care 2011 Aug;34(8):1689-1694 [FREE Full text] [CrossRef] [Medline]
    42. Turchin A, Goldberg SI, Shubina M, Einbinder JS, Conlin PR. Encounter frequency and blood pressure in hypertensive patients with diabetes mellitus. Hypertension 2010 Jul;56(1):68-74 [FREE Full text] [CrossRef] [Medline]
    43. Helou N, Dwyer A, Shaha M, Zanchi A. Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis. JBI Database System Rev Implement Rep 2016 Dec;14(7):169-207. [CrossRef] [Medline]
    44. Einstadter D, Bolen SD, Misak JE, Bar-Shain DS, Cebul RD. Association of repeated measurements with blood pressure control in primary care. JAMA Intern Med 2018 Jun 01;178(6):858-860 [FREE Full text] [CrossRef] [Medline]
    45. Choi S, Shin J, Choi SY, Sung KC, Ihm SH, Kim K, et al. Impact of visit-to-visit variability in systolic blood pressure on cardiovascular outcomes in Korean National Health Insurance Service-National Sample Cohort. Am J Hypertens 2017 Jun 01;30(6):577-586. [CrossRef] [Medline]
    46. Wu C, Shlipak MG, Stawski RS, Peralta CA, Psaty BM, Harris TB, Health ABC Study. Visit-to-visit blood pressure variability and mortality and cardiovascular outcomes among older adults: the health, aging, and body composition study. Am J Hypertens 2017 Feb;30(2):151-158 [FREE Full text] [CrossRef] [Medline]

    ‎
    BP: blood pressure
    DBP: diastolic blood pressure
    DKD: diabetic kidney disease
    EHR: electronic health record
    FQHC: federally qualified health center
    ICD: International Classification of Diseases
    mHealth: mobile health
    SBP: systolic blood pressure
    STOP-DKD APP: Simultaneous Risk Factor Control Using Telehealth to Slow Progression of Diabetic Kidney Disease Automated Population Program
    VA: Veterans Affairs

    Edited by G Eysenbach; submitted 18.10.18; peer-reviewed by CS Hung, D Robinson; comments to author 12.12.18; revised version received 26.01.19; accepted 27.01.19; published 09.04.19

    Copyright

    ©Allison A Lewinski, Uptal D Patel, Clarissa J Diamantidis, Megan Oakes, Khaula Baloch, Matthew J Crowley, Jonathan Wilson, Jane Pendergast, Holly Biola, L Ebony Boulware, Hayden B Bosworth. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 09.04.2019.

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included.